| 篇名 |
出處 |
推薦原因 |
|
SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review
|
"Mayo Clin Proc. 2020 Aug;95(8):1750-1765. doi: 10.1016/j.mayocp.2020.05.011. Epub 2020 May 30. "
|
本篇文章提出面對感染COVID-19的懷孕婦女目前可行的治療方針，在臨床上或許能幫助在處理這類的患者上有個可依循的準則。
|
|
International Society for Gynecologic endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic
|
Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:133-140. doi: 10.1016/j.ejogrb.2020.08.039. Epub 2020 Aug 26.
|
"The International Society for Gynecologic Endoscopy (ISGE) 就Covid-19世界流行的年代，對於需接受內視鏡手術的狀況，提出臨床指引。 "
|
|
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
|
Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.
|
文中提出關於Triple combination的治療方式。
|
|
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cell
|
Stem Cell Res Ther. 2020 Aug 18;11(1):361. doi: 10.1186/s13287-020-01875-5.
|
討論關於HUC-MSCs治療。
|
|
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality
|
Med Hypotheses. 2020 Jul;140:109760. doi: 10.1016/j.mehy.2020.109760. Epub 2020 Apr 22.
|
高壓氧、輸紅血球治療、或是促紅血球生成素(ESA)治療，可以增加組織的氧合作用，來輔助治療COVID-19。
|
|
Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review
|
Arch Acad Emerg Med. 2020 Mar 23;8(1):e34. eCollection 2020.
|
當今大流行的COVID-19目前已知孕婦感染所造成的症狀多與一般患者無異，目前已知懷孕的影響為胎兒窘迫及早期破水，但沒有實驗證據顯示會對新生兒造成影響或垂直傳染。
|